Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil effects on sleep in Alzheimer's disease
NCT00480870Phase 4Completed
- Sponsor
- AFIP
- Start
- Apr 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Alzheimer's disease (AD) comparing Donepezil with Placebo (2 arms). Primary endpoint: Polysomnography parameters (sleep structure, respiratory, limb movements) at 6 months. Started Apr 1999; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00480870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00480870.